Takhzyro

Product manufactured by Dyax Corp.

Application Nr Approved Date Route Status External Links
BLA761090 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Takhzyroâ„¢ Is Indicated For Prophylaxis To Prevent Attacks Of Hereditary Angioedema (Hae) In Patients 12 Years And Older. Takhzyro Is A Plasma Kallikrein Inhibitor (Monoclonal Antibody) Indicated For Prophylaxis To Prevent Attacks Of Hereditary Angioedema (Hae) In Patients 12 Years And Older. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Lanadelumab

Comments